DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
Vaso-Occlusive Crisis: The Future of Treating Patients With Sickle Cell Disease in Emergency Departments
Claudia Morris, MD, Childrens Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, has been studying arginine (Arg) as a therapeutic option for sickle cell disease (SCD) for years. Recently, her research revealed groundbreaking findings of the effects of Arg on patients experiencing a vaso-occlusive episode (VOE).
While statistically insignificant, results showed a clinically relevant decrease in total parenteral opioid (TPO) and a shortened time to crisis resolution in both intervention groups treated with Arg compared with placebo. Arginine is approved by the FDA for growth hormone stimulation, and because of that investigators have access to 50 years worth of safety information, despite the lack of use for treating VOEs. “The challenge right now is that we have no therapies in the emergency department to treat acute pain, outside of pain medications and IV opioids,” Morris said.
education & researchCDC grand rounds: Improving the lives of persons with sickle cell diseaseApproximately 100,000 Americans have sic...
news & eventsRARE Patient Advocacy SummitEach year, Global Genes convenes one of ...
education & researchPatterns of opioid use in sickle cell diseasePain, the hallmark complication of sickl...
news & events10th DC Community Health Connect Event by Rodham InstituteThis event has ended. Stay tuned for upc...
news & eventsWebinar Series: Sickle Cell Science: Path to Progress – Sickle Cell Disease Care in the Emergency Department: ...To commemorate Sickle Cell Awareness Mon...
news & eventsEffort set to help sickle cell patients manage medsVanderbilt University Medical Center is ...
people & placesNYC Health + HospitalsNYC Health + Hospitals are the largest p...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.